Clinical Trial Update: A Study of E6005 in Japanese Patients With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

The update reports the completion of Phase 1 and Phase 2 studies of the investigational drug E6005 in Japanese patients with Atopic Dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• E6005

Snippet

Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED